Human Anti-CD3 x Anti-TROP2 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H281)
Anti-CD3 x Anti-TROP2 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-TROP2 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Pancreatic cancer; Breast cancer; Gastrointestinal cancer; Cancers therapy.
There are currently no customer reviews or questions for Human Anti-CD3 x Anti-TROP2 Bispecific Antibody (IgG-IgG) (BSIG-H281). Click the button below to contact us or submit your feedback about this product.